RediTrex
Rheumatoid Arthritis
MarketedCommercial
Key Facts
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharma company with a mission to improve patient care by providing branded therapeutic solutions in niche hospital and gastroenterology markets. Its core achievement is building and sustaining a portfolio of commercial products like Caldolor and Acetadote through strategic acquisition and lifecycle management. The company's strategy avoids blockbuster competition by focusing on specialized acute care areas, leveraging a targeted commercial team. As a small-cap public company, it operates with a lean model aimed at generating stable revenue from its established products while selectively pursuing pipeline expansion.
View full company profileTherapeutic Areas
Other Rheumatoid Arthritis Drugs
| Drug | Company | Phase |
|---|---|---|
| Early Detection Test for Rheumatoid Arthritis | Age Labs | Development |
| Piclidenoson (CF101) | Can Fite Biopharma | Phase II/III |
| ERNA-201 | Eterna Therapeutics | Preclinical |
| Tc99m Tilmanocept | Navidea Biopharmaceuticals | Phase 2/3 |
| Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure) | LFB | Pre-clinical |
| EYD-001 (Takinib analog) | EydisBio | Preclinical |
| LFD-200 | Lifordi Immunotherapeutics | Phase 1 |
| MEV-N01 | Mesenbio | Pre-clinical |
| CIT-013 | Citryll | Phase 2a |
| Restem-L | Restem | Phase 2 |
| ASIT Platform | Ahead Therapeutics | Pre-clinical |
| AX-158 | Artax Biopharma | Phase 2 |